Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bremelanotide acetate by Cosette Pharmaceuticals for Obesity: Likelihood of Approval
Bremelanotide acetate is under clinical development by Cosette Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase...
Data Insights
Bremelanotide acetate by Cosette Pharmaceuticals for Diabetic Nephropathy: Likelihood of Approval
Bremelanotide acetate is under clinical development by Cosette Pharmaceuticals and currently in Phase II for Diabetic Nephropathy. According to GlobalData,...